These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 21778195)

  • 21. Mutation at embB codon 306, a potential marker for the identification of multidrug resistance associated with ethambutol in Mycobacterium tuberculosis.
    Cuevas-Córdoba B; Juárez-Eusebio DM; Almaraz-Velasco R; Muñiz-Salazar R; Laniado-Laborin R; Zenteno-Cuevas R
    Antimicrob Agents Chemother; 2015 Sep; 59(9):5455-62. PubMed ID: 26124153
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mutations at embB codon 306 are an important molecular indicator of ethambutol resistance in Mycobacterium tuberculosis.
    Starks AM; Gumusboga A; Plikaytis BB; Shinnick TM; Posey JE
    Antimicrob Agents Chemother; 2009 Mar; 53(3):1061-6. PubMed ID: 19104018
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quadruple-first line drug resistance in Mycobacterium tuberculosis in Vietnam: What can we learn from genes?
    Nguyen HQ; Nguyen NV; Contamin L; Tran THT; Vu TT; Nguyen HV; Nguyen NLT; Nguyen ST; Dang AD; Bañuls AL; Nguyen VAT
    Infect Genet Evol; 2017 Jun; 50():55-61. PubMed ID: 28214557
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Detection of embB306 mutations in ethambutol-susceptible clinical isolates of Mycobacterium tuberculosis from Northwestern Russia: implications for genotypic resistance testing.
    Mokrousov I; Otten T; Vyshnevskiy B; Narvskaya O
    J Clin Microbiol; 2002 Oct; 40(10):3810-3. PubMed ID: 12354887
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Detection of mutations associated with multidrug-resistant Mycobacterium tuberculosis clinical isolates.
    Nimri L; Samara H; Batchoun R
    FEMS Immunol Med Microbiol; 2011 Aug; 62(3):321-7. PubMed ID: 21569121
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Detection by GenoType MTBDRsl test of complex mechanisms of resistance to second-line drugs and ethambutol in multidrug-resistant Mycobacterium tuberculosis complex isolates.
    Brossier F; Veziris N; Aubry A; Jarlier V; Sougakoff W
    J Clin Microbiol; 2010 May; 48(5):1683-9. PubMed ID: 20335420
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mechanisms of first-line antimicrobial resistance in multi-drug and extensively drug resistant strains of Mycobacterium tuberculosis in KwaZulu-Natal, South Africa.
    Dookie N; Sturm AW; Moodley P
    BMC Infect Dis; 2016 Oct; 16(1):609. PubMed ID: 27784282
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Minor contribution of mutations at iniA codon 501 and embC-embA intergenic region in ethambutol-resistant clinical Mycobacterium tuberculosis isolates in Kuwait.
    Jaber AA; Ahmad S; Mokaddas E
    Ann Clin Microbiol Antimicrob; 2009 Jan; 8():2. PubMed ID: 19146672
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Analysis of gene mutations associated with isoniazid, rifampicin and ethambutol resistance among Mycobacterium tuberculosis isolates from Ethiopia.
    Tessema B; Beer J; Emmrich F; Sack U; Rodloff AC
    BMC Infect Dis; 2012 Feb; 12():37. PubMed ID: 22325147
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of embB codon 306 mutations in Mycobacterium tuberculosis revisited: a novel association with broad drug resistance and IS6110 clustering rather than ethambutol resistance.
    Hazbón MH; Bobadilla del Valle M; Guerrero MI; Varma-Basil M; Filliol I; Cavatore M; Colangeli R; Safi H; Billman-Jacobe H; Lavender C; Fyfe J; García-García L; Davidow A; Brimacombe M; León CI; Porras T; Bose M; Chaves F; Eisenach KD; Sifuentes-Osornio J; Ponce de León A; Cave MD; Alland D
    Antimicrob Agents Chemother; 2005 Sep; 49(9):3794-802. PubMed ID: 16127055
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prediction of drug resistance by Sanger sequencing of Mycobacterium tuberculosis complex strains isolated from multidrug resistant tuberculosis suspect patients in Ethiopia.
    Mesfin EA; Merker M; Beyene D; Tesfaye A; Shuaib YA; Addise D; Tessema B; Niemann S
    PLoS One; 2022; 17(8):e0271508. PubMed ID: 35930613
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multicenter evaluation of reverse line blot assay for detection of drug resistance in Mycobacterium tuberculosis clinical isolates.
    Mokrousov I; Bhanu NV; Suffys PN; Kadival GV; Yap SF; Cho SN; Jordaan AM; Narvskaya O; Singh UB; Gomes HM; Lee H; Kulkarni SP; Lim KC; Khan BK; van Soolingen D; Victor TC; Schouls LM
    J Microbiol Methods; 2004 Jun; 57(3):323-35. PubMed ID: 15134881
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mutations Found in embCAB, embR, and ubiA Genes of Ethambutol-Sensitive and -Resistant Mycobacterium tuberculosis Clinical Isolates from China.
    Xu Y; Jia H; Huang H; Sun Z; Zhang Z
    Biomed Res Int; 2015; 2015():951706. PubMed ID: 26417605
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Population genetics study of isoniazid resistance mutations and evolution of multidrug-resistant Mycobacterium tuberculosis.
    Hazbón MH; Brimacombe M; Bobadilla del Valle M; Cavatore M; Guerrero MI; Varma-Basil M; Billman-Jacobe H; Lavender C; Fyfe J; García-García L; León CI; Bose M; Chaves F; Murray M; Eisenach KD; Sifuentes-Osornio J; Cave MD; Ponce de León A; Alland D
    Antimicrob Agents Chemother; 2006 Aug; 50(8):2640-9. PubMed ID: 16870753
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mutations in the embB gene and their association with ethambutol resistance in multidrug-resistant Mycobacterium tuberculosis clinical isolates from Poland.
    Bakuła Z; Napiórkowska A; Bielecki J; Augustynowicz-Kopeć E; Zwolska Z; Jagielski T
    Biomed Res Int; 2013; 2013():167954. PubMed ID: 24392447
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular detection of Isoniazid, Rifampin and Ethambutol resistance to M. tuberculosis and M. bovis in multidrug resistant tuberculosis (MDR-TB) patients in Pakistan.
    Munir S; Mahmood N; Shahid S; Khan MI
    Microb Pathog; 2017 Sep; 110():262-274. PubMed ID: 28688981
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Whole-genome sequencing in drug susceptibility testing of Mycobacterium tuberculosis in routine practice in Lyon, France.
    Genestet C; Hodille E; Berland JL; Ginevra C; Bryant JE; Ader F; Lina G; Dumitrescu O;
    Int J Antimicrob Agents; 2020 Apr; 55(4):105912. PubMed ID: 31991222
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular characterization of multidrug-resistant Mycobacterium tuberculosis (MDR-TB) isolates identifies local transmission of infection in Kuwait, a country with a low incidence of TB and MDR-TB.
    Al-Mutairi NM; Ahmad S; Mokaddas EM
    Eur J Med Res; 2019 Dec; 24(1):38. PubMed ID: 31806020
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genetic characterisation of the ethambutol resistance-determining region in Mycobacterium tuberculosis: prevalence and significance of embB306 mutations.
    Perdigão J; Macedo R; Ribeiro A; Brum L; Portugal I
    Int J Antimicrob Agents; 2009 Apr; 33(4):334-8. PubMed ID: 19097862
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ethambutol resistance in Mycobacterium tuberculosis: critical role of embB mutations.
    Sreevatsan S; Stockbauer KE; Pan X; Kreiswirth BN; Moghazeh SL; Jacobs WR; Telenti A; Musser JM
    Antimicrob Agents Chemother; 1997 Aug; 41(8):1677-81. PubMed ID: 9257740
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.